Does segmental difference in α1-adrenoceptor subtype explain contractile difference in rat abdominal and thoracic aortae?

Vascular Pharmacology

Volumn 38, Issue 3, 2002, Pages 169-175

  Asbún Bojalil, Juan ^a   Castillo, Enrique F ^a   Escalante, Bruno A ^b   Castillo, Carlos ^a  

^a Secc Estud Posgrado Invest E   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

1D Adrenoceptors; Phenylephrine; Rat aorta

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; INDOMETACIN; PHENYLEPHRINE; PRAZOSIN; RECEPTOR SUBTYPE;

ABDOMINAL AORTA; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; DRUG RECEPTOR BINDING; ENDOTHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; AORTA, ABDOMINAL; AORTA, THORACIC; ENDOTHELIUM, VASCULAR; INDOMETHACIN; ISOMETRIC CONTRACTION; MALE; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; VASOCONSTRICTOR AGENTS;

EID: 0036524537     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(02)00164-7     Document Type: Article

References (33)

1. 1 adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Br. J. Pharmacol. 109:1993;80-87.
2. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14:1959;48-58.
3. Asbun-Bojalil J., Escalante B., Ceballos G., Ocharán M.E., Castillo E.F., Castillo C. Segmental differences in rat aorta contraction induced by phenylephrine in aortic rings. Proc. West Pharmacol. Soc. 42:1999;23-24.
4. 1D subtype. Eur. J. Pharmacol. 297:1996;241-248.
5. 1D-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br. J. Pharmacol. 119:1996;269-276.
6. q/11-coupled receptor stimulation. Naunyn-Schmiedeberg's Arch. Pharmacol. 363:2001;322-329.
7. Exton J.H. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. Annu. Rev. Pharmacol. Toxicol. 36:1996;481-509.
8. 1-adrenoceptors. Eur. J. Pharmacol. 272:1994;R5.
9. Gu H., Trajkovic S., La Belle E.F. Norepinephrine-induced phosphatidylcholine hydrolysis by phospholipases D and C in rat tail artery. Am. J. Physiol. 262:1992;C1376-C1383.
10. 2+ in smooth muscle. Nature. 329:1987;333-335.
11. 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br. J. Pharmacol. 97:1989;691-700.
12. 1-adrenoceptors: consensus update. Pharmacol. Rev. 47:1995;267-270.
13. Kaiser L., Tithof P.K., Lamb V.L., Williams J.F. Depression of endothelium-dependent relaxation in aorta from rats with Brugia pahagi lymphatic filariasis. Circ. Res. 68:1991;1703-1712.
14. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol. 115:1995;981-986.
15. Lamb V.L., Schwartz A.J., Rohn W.R., Kaiser L. Cyclooxygenase inhibitors depress norepinephrine constriction of rat abdominal, but not thoracic, aorta. Eur. J. Pharmacol. 256:1994;221-226.
16. 2+. Pharmacol. Rev. 40:1988;87-119.
17. Nebigil C., Malik K.U. Comparison of signal transduction mechanisms of alpha-2C and alpha-1A adrenergic receptor-stimulated prostaglandin synthesis. J. Pharmacol. Exp. Ther. 263:1992;987-996.
18. Nebigil C., Malik K.U. Prostaglandin synthesis elicited by adrenergic stimuli is mediated via alpha-2C and alpha-1A adrenergic receptors in cultured smooth muscle cells of rabbit aorta. J. Pharmacol. Exp. Ther. 260:1992;849-858.
19. ++ channels through a pertussis toxin-sensitive guanine nucleotide-binding protein. J. Pharmacol. Exp. Ther. 266:1993;1113-1124.
20. 1D-adrenergic receptors to multiple signaling pathways is both G-protein and cell type specific. Mol. Pharmacol. 44:1993;784-795.
21. 1-adrenoceptors of vascular smooth muscle. Mol. Pharmacol. 46:1994;30-40.
22. 1D-adrenoceptor to the contraction of vascular smooth muscle. J. Pharmacol. Exp. Ther. 275:1995;1583-1589.
23. Piascik M.T., Hrometz S.L., Edelmann S.E., Guarino R.D., Hadley R.W., Brown R.D. Immunocytochemical localization of the alpha-1B adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. J. Pharmacol. Exp. Ther. 283:1997;854-868.
24. Ruan Y., Kan H., Parmentier J.-H., Fatima S., Allen L.F., Malik K.U. Alpha-1A adrenergic receptor stimulation with phenylephrine promotes arachidonic acid release by activation of phospholipase D in rat-1 fibroblasts: inhibition by protein kinase A. Am. J. Pharmacol. Exp. Ther. 284:1998;575-585.
25. 1D adrenoceptors. Can. J. Physiol. Pharmacol. 72:1994;A323.
26. Saussy D.L., Goetz A.S., Queen K.L., King H.K., Lutz M.W., Rimele T.J. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. J. Pharmacol. Exp. Ther. 278:1996;136-144.
27. Scofield M.A., Liu F., Abel P.W., Jeffries W.B. Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J. Pharmacol. Exp. Ther. 75:1995;1035-1042.
28. Tallarida R.J., Murray R.B. Manual of Pharmacologic Calculations with Computer Programs. second ed. 1987;Springer-Verlag, New York.
29. 1D-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta. Pharmacol. Lett. 57(13):1995;159-163.
30. 1A subtypes. Eur. J. Pharmacol. 298:1996;257-263.
31. 1-adrenergic receptors is mediated by the alpha subunits of Gq family. J. Biol. Chem. 267:1992;25798-25802.
32. 1-adrenoceptor subtypes in rat aorta by solution hybridization. Life Sci. 21:1996;PL343-PL347.
33. 1-adrenoceptor subtypes in aortas of 12-month-old spontaneously hypertensive rats. Eur. J. Pharmacol. 344:1998;31-36.